Transcend Capital Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,200
| Closed | -$260K | – | 513 |
|
|
2022
Q3 | $260K | Buy |
2,200
+33
| +2% | +$3.9K | 0.03% | 388 |
|
|
2022
Q2 | $310K | Buy |
+2,167
| New | +$310K | 0.03% | 371 |
|
|
2022
Q1 | – | Sell |
-4,706
| Closed | -$1.2M | – | 535 |
|
|
2021
Q4 | $1.2M | Buy |
4,706
+328
| +7% | +$83.3K | 0.11% | 195 |
|
|
2021
Q3 | $1.51M | Buy |
+4,378
| New | +$1.51M | 0.14% | 166 |
|